查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1595208

腸外營養市場：按營養類型、劑型和最終用戶分類 - 全球預測 2025-2030

Parenteral Nutrition Market by Nutrient Type (Amino Acids, Carbohydrates, Electrolytes), Dosage Form (Ampules, Bags, Bottles), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年腸外營養市場價值為76.7億美元，預計到2024年將達到83.3億美元，複合年成長率為8.66%，到2030年將達到137.3億美元。

腸外營養 (PN) 是指繞過胃腸道，將營養物質直接輸送到血液中，適用於通常因醫療狀況而無法攝取或吸收足夠營養物質的患者。患有胃腸道疾病的患者、經歷治療副作用的腫瘤患者以及需要生長和發育必需營養素的早產兒也需要 PN。 PN 主要在醫院、門診診所和家庭醫療機構進行。在醫療保健技術創新和需要長期營養支持的慢性病盛行率上升的推動下，市場需求不斷成長。主要成長動力包括營養不良和胃腸道疾病發生率上升、先進的醫療基礎設施以及經常需要營養干預的人口老化。潛在的商機在於開發更有效率、更安全的 PN 配方，並增強針對患者的客製化能力。開拓醫療保健基礎設施正在開發的新興市場也是一個重要的成長機會。然而，PN 解決方案的高成本、複雜的監管核准以及感染疾病和代謝異常等併發症的風險等挑戰正在阻礙市場擴張。 PN 的創新可能會集中在提高營養素的生物利用度、降低醫療保健相關風險以及採用數位健康技術來更好地監測和管理。利用先進的資料分析和遺傳資訊探索個人化營養解決方案是一個有前景的市場成長領域。市場競爭激烈，主要企業在不斷創新，以提高產品的有效性和安全性。對於希望在不斷變化的環境中取得成功的企業來說，及時了解監管環境的變化和技術進步至關重要。總之，如果企業能夠透過策略創新並向開拓地區擴張來克服現有挑戰，PN 市場潛力巨大。

主要市場統計
基準年[2023] 76.7億美元
預測年份 [2024] 83.3億美元
預測年份 [2030] 137.3億美元
複合年成長率（%） 8.66%

市場動態：快速發展的腸外營養市場的關鍵市場洞察

供需的動態交互作用正在改變腸外營養市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 腎臟病、肝病和癌症等慢性疾病的盛行率
    • 老年人口和營養不良人口比例不斷增加
    • 世界各地的高出生率和早產
  • 市場限制因素
    • 嚴格的政府法規對腸外營養核准
  • 市場機會
    • 創新的腸外和經腸營養治療
    • 腸外營養技術發展
  • 市場挑戰
    • 與腸外營養相關的複雜性

波特五力策略工具駕馭腸外營養市場

波特的五力架構是了解腸外營養品市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解腸外營養市場的外部影響

外部宏觀環境因素在塑造腸外營養補充品市場的表現動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解腸外營養市場的競爭狀況

對腸外營養補充劑市場的詳細市場佔有率分析可以對供應商的業績進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣腸外營養市場供應商績效評估

FPNV定位矩陣是評估腸外營養市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了腸外營養市場的成功之路

對於旨在加強在全球市場的影響力的公司來說，腸外營養市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 腎臟病、肝病和癌症等慢性疾病的盛行率
      • 老年人口增加及營養不良
      • 全球高出生率和早產率呈上升趨勢
    • 抑制因素
      • 嚴格的政府法規對腸外營養核准
    • 機會
      • 創新的腸外和經腸營養治療
      • 腸外營養技術發展
    • 任務
      • 與腸外營養相關的複雜性
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章依營養類型分類的腸外營養市場

  • 胺基酸
  • 碳水化合物
  • 電解質
  • 脂質
  • 綜合維他命組合和微量元素

第7章依劑型分類的腸外營養市場

  • 安瓿
  • 包包
  • 瓶子
  • 管瓶

第8章 腸外營養市場：依最終用戶分類

  • 診所
  • 醫院
  • 長期照護服務提供者

第9章美洲腸外營養市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太腸外營養市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲腸外營養市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • AbbVie Inc.
  • ACULIFE HEALTHCARE PRIVATE LIMITED
  • ALBERT DAVID LIMITED by Kothari Group
  • Amanta Healthcare Ltd.
  • AMINO GmbH
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Claris Lifesciences Limited
  • Evonik Industries AG
  • Fresenius Kabi AG
  • Grifols SA
  • Hamilton Bonaduz AG
  • ICU Medical, Inc.
  • Otsuka Holdings Co., Ltd.
  • Pfizer Inc.
  • Sichuan Kelun Pharmaceutical Co., Ltd.
  • Well Pharma Medical Solutions LLC
Product Code: MRR-036C5CF3B549

The Parenteral Nutrition Market was valued at USD 7.67 billion in 2023, expected to reach USD 8.33 billion in 2024, and is projected to grow at a CAGR of 8.66%, to USD 13.73 billion by 2030.

Parenteral nutrition (PN) involves delivering nutrients directly into the bloodstream, bypassing the gastrointestinal tract, usually for patients unable to ingest or absorb enough nutrients due to medical conditions. The necessity of PN extends to patients with gastrointestinal disorders, oncology patients experiencing side effects from their treatment, and premature infants who require essential nutrients for growth and development. PN is primarily applied in hospitals, outpatient clinics, and home healthcare settings. Driven by innovations in healthcare technology and the rising prevalence of chronic diseases requiring long-term nutritional support, the market sees growing demand. Key growth drivers include the increasing rate of malnutrition and gastrointestinal diseases, advanced healthcare infrastructure, and a rise in the aging population that often requires nutritional interventions. Potential opportunities lie in the development of more efficient, safer PN formulations with enhanced patient-specific customization capabilities. Expanding access to emerging markets, where healthcare infrastructure is developing, also presents a significant growth opportunity. However, challenges such as the high cost of PN solutions, complex regulatory approvals, and risks of complications like infections and metabolic abnormalities hinder market expansion. Innovations in PN might focus on improving the bioavailability of nutrients, reducing healthcare-associated risks, and employing digital health technologies for better monitoring and administration. Research into personalized nutrition solutions, utilizing advanced data analytics and genetic information, offers a promising area for market growth. The market's nature is highly competitive, with key players constantly innovating to improve product efficacy and safety. Staying abreast of regulatory changes and technological advancements will be crucial for businesses aiming to succeed in this evolving landscape. In conclusion, the PN market holds significant potential, provided companies can navigate the existing challenges through strategic innovation and expansion into untapped regions.

KEY MARKET STATISTICS
Base Year [2023] USD 7.67 billion
Estimated Year [2024] USD 8.33 billion
Forecast Year [2030] USD 13.73 billion
CAGR (%) 8.66%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Parenteral Nutrition Market

The Parenteral Nutrition Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Prevalence of chronic diseases such as kidney diseases, liver diseases and cancer
    • Increasing rate of geriatric population and malnourished individuals
    • High natality and premature births around the globe
  • Market Restraints
    • Strict government rules regarding the approval of parenteral nutrition
  • Market Opportunities
    • Innovative parenteral and enteral nutrition therapy
    • Technological developments in parenteral nutrition
  • Market Challenges
    • Associated complexities with parenteral nutrition

Porter's Five Forces: A Strategic Tool for Navigating the Parenteral Nutrition Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Parenteral Nutrition Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Parenteral Nutrition Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Parenteral Nutrition Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Parenteral Nutrition Market

A detailed market share analysis in the Parenteral Nutrition Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Parenteral Nutrition Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Parenteral Nutrition Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Parenteral Nutrition Market

A strategic analysis of the Parenteral Nutrition Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Parenteral Nutrition Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., ACULIFE HEALTHCARE PRIVATE LIMITED, ALBERT DAVID LIMITED by Kothari Group, Amanta Healthcare Ltd., AMINO GmbH, B. Braun Melsungen AG, Baxter International Inc., Claris Lifesciences Limited, Evonik Industries AG, Fresenius Kabi AG, Grifols S.A., Hamilton Bonaduz AG, ICU Medical, Inc., Otsuka Holdings Co., Ltd., Pfizer Inc., Sichuan Kelun Pharmaceutical Co., Ltd., and Well Pharma Medical Solutions LLC.

Market Segmentation & Coverage

This research report categorizes the Parenteral Nutrition Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Nutrient Type, market is studied across Amino Acids, Carbohydrates, Electrolytes, Lipids, and Multivitamin Formulations & Trace Elements.
  • Based on Dosage Form, market is studied across Ampules, Bags, Bottles, and Vials.
  • Based on End-User, market is studied across Clinics, Hospitals, and Long-Term Care Providers.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of chronic diseases such as kidney diseases, liver diseases and cancer
      • 5.1.1.2. Increasing rate of geriatric population and malnourished individuals
      • 5.1.1.3. High natality and premature births around the globe
    • 5.1.2. Restraints
      • 5.1.2.1. Strict government rules regarding the approval of parenteral nutrition
    • 5.1.3. Opportunities
      • 5.1.3.1. Innovative parenteral and enteral nutrition therapy
      • 5.1.3.2. Technological developments in parenteral nutrition
    • 5.1.4. Challenges
      • 5.1.4.1. Associated complexities with parenteral nutrition
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Parenteral Nutrition Market, by Nutrient Type

  • 6.1. Introduction
  • 6.2. Amino Acids
  • 6.3. Carbohydrates
  • 6.4. Electrolytes
  • 6.5. Lipids
  • 6.6. Multivitamin Formulations & Trace Elements

7. Parenteral Nutrition Market, by Dosage Form

  • 7.1. Introduction
  • 7.2. Ampules
  • 7.3. Bags
  • 7.4. Bottles
  • 7.5. Vials

8. Parenteral Nutrition Market, by End-User

  • 8.1. Introduction
  • 8.2. Clinics
  • 8.3. Hospitals
  • 8.4. Long-Term Care Providers

9. Americas Parenteral Nutrition Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Parenteral Nutrition Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Parenteral Nutrition Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AbbVie Inc.
  • 2. ACULIFE HEALTHCARE PRIVATE LIMITED
  • 3. ALBERT DAVID LIMITED by Kothari Group
  • 4. Amanta Healthcare Ltd.
  • 5. AMINO GmbH
  • 6. B. Braun Melsungen AG
  • 7. Baxter International Inc.
  • 8. Claris Lifesciences Limited
  • 9. Evonik Industries AG
  • 10. Fresenius Kabi AG
  • 11. Grifols S.A.
  • 12. Hamilton Bonaduz AG
  • 13. ICU Medical, Inc.
  • 14. Otsuka Holdings Co., Ltd.
  • 15. Pfizer Inc.
  • 16. Sichuan Kelun Pharmaceutical Co., Ltd.
  • 17. Well Pharma Medical Solutions LLC

LIST OF FIGURES

  • FIGURE 1. PARENTERAL NUTRITION MARKET RESEARCH PROCESS
  • FIGURE 2. PARENTERAL NUTRITION MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL PARENTERAL NUTRITION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS PARENTERAL NUTRITION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS PARENTERAL NUTRITION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES PARENTERAL NUTRITION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES PARENTERAL NUTRITION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC PARENTERAL NUTRITION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC PARENTERAL NUTRITION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PARENTERAL NUTRITION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PARENTERAL NUTRITION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. PARENTERAL NUTRITION MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. PARENTERAL NUTRITION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PARENTERAL NUTRITION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PARENTERAL NUTRITION MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. PARENTERAL NUTRITION MARKET DYNAMICS
  • TABLE 7. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY AMINO ACIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY CARBOHYDRATES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY ELECTROLYTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY LIPIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY MULTIVITAMIN FORMULATIONS & TRACE ELEMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY AMPULES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY BAGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY BOTTLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY VIALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY LONG-TERM CARE PROVIDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS PARENTERAL NUTRITION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES PARENTERAL NUTRITION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC PARENTERAL NUTRITION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. AUSTRALIA PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 48. AUSTRALIA PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. CHINA PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. CHINA PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 51. CHINA PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. INDIA PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. INDIA PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 54. INDIA PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. INDONESIA PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. INDONESIA PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 57. INDONESIA PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. JAPAN PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. JAPAN PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 60. JAPAN PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. MALAYSIA PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. MALAYSIA PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 63. MALAYSIA PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. PHILIPPINES PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. PHILIPPINES PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 66. PHILIPPINES PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. SINGAPORE PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. SINGAPORE PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 69. SINGAPORE PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. SOUTH KOREA PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. SOUTH KOREA PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 72. SOUTH KOREA PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. TAIWAN PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. TAIWAN PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 75. TAIWAN PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. THAILAND PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. THAILAND PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 78. THAILAND PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. VIETNAM PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. VIETNAM PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 81. VIETNAM PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA PARENTERAL NUTRITION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 86. DENMARK PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. DENMARK PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 88. DENMARK PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. EGYPT PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. EGYPT PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 91. EGYPT PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. FINLAND PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. FINLAND PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 94. FINLAND PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. FRANCE PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. FRANCE PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 97. FRANCE PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. GERMANY PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. GERMANY PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 100. GERMANY PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. ISRAEL PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. ISRAEL PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 103. ISRAEL PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. ITALY PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. ITALY PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 106. ITALY PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. NETHERLANDS PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. NETHERLANDS PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 109. NETHERLANDS PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. NIGERIA PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. NIGERIA PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 112. NIGERIA PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. NORWAY PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. NORWAY PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 115. NORWAY PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. POLAND PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. POLAND PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 118. POLAND PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. QATAR PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. QATAR PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 121. QATAR PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. RUSSIA PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. RUSSIA PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 124. RUSSIA PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. SAUDI ARABIA PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. SAUDI ARABIA PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 127. SAUDI ARABIA PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH AFRICA PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH AFRICA PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH AFRICA PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. SPAIN PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. SPAIN PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 133. SPAIN PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. SWEDEN PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. SWEDEN PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 136. SWEDEN PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. SWITZERLAND PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. SWITZERLAND PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 139. SWITZERLAND PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. TURKEY PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. TURKEY PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 142. TURKEY PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED ARAB EMIRATES PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED ARAB EMIRATES PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED ARAB EMIRATES PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED KINGDOM PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED KINGDOM PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED KINGDOM PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 149. PARENTERAL NUTRITION MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 150. PARENTERAL NUTRITION MARKET, FPNV POSITIONING MATRIX, 2023